AAAAAA
Results: 1-25/26
Authors:
RICHARD JM
SANCHOGARNIER H
PESSEY JJ
LUBOINSKI B
LEFEBVRE JL
DEHESDIN D
STROMBONILUBOINSKI M
HILL C
Citation: Jm. Richard et al., RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY IN LARYNX-CARCINOMA, Oral Oncology, 34(3), 1998, pp. 224-228
Authors:
BARZAN L
TIRELLI U
LEFEBVRE JL
Citation: L. Barzan et al., HEAD AND NECK-CANCER, Critical reviews in oncology/hematology, 27(2), 1998, pp. 155-156
Authors:
LEFEBVRE JL
Citation: Jl. Lefebvre, LARYNX PRESERVATION - WHAT HAVE WE LEARNED - (INVITED ABSTRACT), Annals of oncology, 9, 1998, pp. 360-360
Authors:
PIVOT X
RAYMOND E
GEDOUIN D
DEGARDIN W
ARMAND JP
LAGUERRE B
LEFEBVRE JL
RIPOCHE V
KAYITALIRE L
SCHNEIDER M
Citation: X. Pivot et al., PHASE-II TRIAL OF MTA (LY231514) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Annals of oncology, 9, 1998, pp. 366-366
Authors:
LEFEBVRE JL
Citation: Jl. Lefebvre, LARYNX PRESERVATION - THE DISCUSSION IS NOT CLOSED, Otolaryngology and head and neck surgery, 118(3), 1998, pp. 389-393
Authors:
LEFEBVRE JL
Citation: Jl. Lefebvre, NONSURGICAL TREATMENT IN PRIMARILY RESECTABLE T3T4 LARYNX AND HYPOPHARYNX SCC, European journal of cancer, 33, 1997, pp. 1310-1310
Authors:
SCHRIJVERS D
LEFEBVRE JL
VERMORKEN JB
Citation: D. Schrijvers et al., ONGOING TRIALS IN PATIENTS WITH HEAD AND NECK-CANCER, European journal of surgical oncology, 23(6), 1997, pp. 476-485
Authors:
SCHWAAB G
LEFEBVRE JL
JULIERON M
Citation: G. Schwaab et al., NASAL AND PARANASAL CYSTIC ADENOID CARCIN OMAS (CYLINDROMAS) AND ESTHESIONEUROMAS - EXPERIENCE OF THE FRENCH CANCER CENTERS ENT GROUP, Neuro-chirurgie, 43(2), 1997, pp. 118-120
Authors:
LEROY X
DELOBELLE A
LEFEBVRE JL
CABARET V
BLOGET F
VILAIN MO
Citation: X. Leroy et al., EPITHELIOID SARCOMA OF THE TONGUE, Journal of Clinical Pathology, 50(10), 1997, pp. 869-870
Authors:
LEFEBVRE JL
CHEVALIER D
LUBOINSKI B
KIRKPATRICK A
COLLETTE L
SAHMOUD T
Citation: Jl. Lefebvre et al., LARYNX PRESERVATION IN PYRIFORM SINUS CANCER - PRELIMINARY-RESULTS OFA EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PHASE-III TRIAL, Journal of the National Cancer Institute, 88(13), 1996, pp. 890-899
Authors:
BOLLA M
LAPLANCHE A
LEFUR R
VAN JT
DOMENGE C
LEFEBVRE JL
LUBOINSKI B
Citation: M. Bolla et al., PREVENTION OF 2ND PRIMARY TUMORS WITH A 2ND-GENERATION RETINOID IN SQUAMOUS-CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX - LONG-TERM FOLLOW-UP, European journal of cancer, 32A(2), 1996, pp. 375-376
Authors:
VERWEIJ J
DEMULDER PHM
DEGRAEFF A
VERMORKEN JB
WILDIERS J
KERGER J
SCHORNAGEL J
COGNETTI F
KIRKPATRICK A
SAHMOUD T
LEFEBVRE JL
Citation: J. Verweij et al., PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK, Annals of oncology, 7(8), 1996, pp. 867-869
Authors:
SCHRAUB S
MERCIER M
ESCHWEGE F
LEFEBVRE JL
VROUSOS C
BARTHOD L
Citation: S. Schraub et al., A NEW QUALITY-OF-LIFE QUESTIONNAIRE FOR H EAD AND NECK CANCERS, Revue d'epidemiologie et de sante publique, 44(4), 1996, pp. 346-357
Authors:
LEFEBVRE JL
BUISSET E
COCHEDEQUEANT B
VAN JT
PREVOST B
HECQUET B
DEMAILLE A
Citation: Jl. Lefebvre et al., EPILARYNX - PHARYNX OR LARYNX, Head & neck, 17(5), 1995, pp. 377-381
Authors:
BOYLE P
MACFARLANE GJ
BLOT WJ
CHIESA F
LEFEBVRE JL
AZUL AM
DEVRIES N
SCULLY C
Citation: P. Boyle et al., EUROPEAN SCHOOL OF ONCOLOGY ADVISORY REPORT TO THE EUROPEAN-COMMISSION FOR THE EUROPE-AGAINST-CANCER PROGRAM - ORAL CARCINOGENESIS IN EUROPE, European journal of cancer. Part B, Oral oncology, 31B(2), 1995, pp. 75-85
Authors:
DOMENGE C
LANCAR R
COCHEDEQUEANT B
LUSINCHI A
LEFEBVRE JL
MARANDAS P
ESCHWEGE F
SANCHOGAMIER H
LUBOINSKI B
Citation: C. Domenge et al., INDUCTION CHEMOTHERAPY BEFORE RADIOTHERAPY IN OROPHARYNGEAL CARCINOMA- A RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 393-393
Authors:
DEGARDIN M
CAPPELAERE P
CATY A
LEFEBVRE JL
Citation: M. Degardin et al., M-VAC CHEMOTHERAPY AND GM-CSF IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)/, European journal of cancer, 31A, 1995, pp. 438-438
Authors:
LEFEBVRE JL
BUISSET E
PREVOST B
VAN JT
CASTELAIN B
Citation: Jl. Lefebvre et al., CONSERVATIVE TREATMENT FOR T1T2 SUPRAGLOTTIC SCC, European journal of cancer, 31A, 1995, pp. 626-626
Authors:
SCHORNAGEL JH
VERWEIJ J
DEMULDER PHM
COGNETTI F
VERMORKEN JB
CAPPELAERE P
ARMAND JP
WILDIERS J
DEGRAEFF A
CLAVEL M
SAHMOUD T
KIRKPATRICK A
LEFEBVRE JL
Citation: Jh. Schornagel et al., RANDOMIZED PHASE-III TRIAL OF EDATREXATE VERSUS METHOTREXATE IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER HEAD AND NECK-CANCER COOPERATIVE GROUP-STUDY/, Journal of clinical oncology, 13(7), 1995, pp. 1649-1655
Authors:
DEGARDIN M
NGUYEN M
BEAURIN D
LESOIN A
FOURNIER C
LEFEBVRE JL
CAPPELAERE P
Citation: M. Degardin et al., HYPERCALCEMIA AND SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - FREQUENCY AND PROGNOSIS, Bulletin du cancer, 82(11), 1995, pp. 975-980
Authors:
LEFEBVRE JL
COCHEDEQUEANT B
BUISSET E
MIRABEL X
VAN JT
PREVOST B
Citation: Jl. Lefebvre et al., MANAGEMENT OF EARLY ORAL CAVITY CANCER - EXPERIENCE OF CENTER-OSCAR-LAMBRET, European journal of cancer. Part B, Oral oncology, 30B(3), 1994, pp. 216-220
Authors:
DEGARDIN M
DOMENGE C
CAPPELAERE P
LUBOINSKI B
NAVARRETE MS
SCOTT JE
LEFEBVRE JL
Citation: M. Degardin et al., A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, European journal of cancer, 30A(7), 1994, pp. 1044-1045
Authors:
LEFEBVRE JL
Citation: Jl. Lefebvre, HEAD AND NECK MULTIPLE CANCERS, Pathologie et biologie, 42(10), 1994, pp. 1044-1045
Authors:
DEMULDER PHM
CAPPELAERE P
COGNETTI F
VERWEIJ J
SCHORNAGEL JH
VERMORKEN JB
KIRKPATRICK A
LEFEBVRE JL
Citation: Phm. Demulder et al., A PHASE-II STUDY OF PIRARUBICIN IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Cancer chemotherapy and pharmacology, 33(5), 1994, pp. 438-440
Authors:
LEFEBVRE JL
VANKEMMEL B
PREVOST B
BUISSET E
COCHEDEQUEANT B
VAN JT
OSZUSTOWICZ T
Citation: Jl. Lefebvre et al., COMPOSITE RESECTION WITH MANDIBULECTOMY IN THE TREATMENT OF POSTEROLATERAL ORAL CAVITY AND LATERAL OROPHARYNX SQUAMOUS-CELL CARCINOMA, The American journal of surgery, 166(4), 1993, pp. 435-439